212 related articles for article (PubMed ID: 10985391)
1. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1.
Odintsova E; Sugiura T; Berditchevski F
Curr Biol; 2000 Aug; 10(16):1009-12. PubMed ID: 10985391
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR.
Odintsova E; Voortman J; Gilbert E; Berditchevski F
J Cell Sci; 2003 Nov; 116(Pt 22):4557-66. PubMed ID: 14576349
[TBL] [Abstract][Full Text] [Related]
4. Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.
Odintsova E; van Niel G; Conjeaud H; Raposo G; Iwamoto R; Mekada E; Berditchevski F
J Biol Chem; 2013 Sep; 288(36):26323-26334. PubMed ID: 23897813
[TBL] [Abstract][Full Text] [Related]
5. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.
Takahashi M; Sugiura T; Abe M; Ishii K; Shirasuna K
Int J Cancer; 2007 Nov; 121(9):1919-1929. PubMed ID: 17621632
[TBL] [Abstract][Full Text] [Related]
6. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
7. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
Malik FA; Sanders AJ; Jiang WG
Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
[TBL] [Abstract][Full Text] [Related]
8. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion.
He B; Liu L; Cook GA; Grgurevich S; Jennings LK; Zhang XA
J Biol Chem; 2005 Feb; 280(5):3346-54. PubMed ID: 15557282
[TBL] [Abstract][Full Text] [Related]
10. Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.
Scarpino S; Duranti E; Giglio S; Di Napoli A; Galafate D; Del Bufalo D; Desideri M; Socciarelli F; Stoppacciaro A; Ruco L
Thyroid; 2013 Sep; 23(9):1127-37. PubMed ID: 23617728
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.
Lagaudrière-Gesbert C; Le Naour F; Lebel-Binay S; Billard M; Lemichez E; Boquet P; Boucheix C; Conjeaud H; Rubinstein E
Cell Immunol; 1997 Dec; 182(2):105-12. PubMed ID: 9514697
[TBL] [Abstract][Full Text] [Related]
12. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
13. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides play an important role in the organization of CD82-enriched microdomains.
Odintsova E; Butters TD; Monti E; Sprong H; van Meer G; Berditchevski F
Biochem J; 2006 Dec; 400(2):315-25. PubMed ID: 16859490
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
16. Distinctive signaling pathways through CD82 and beta1 integrins in human T cells.
Iwata S; Kobayashi H; Miyake-Nishijima R; Sasaki T; Souta-Kuribara A; Nori M; Hosono O; Kawasaki H; Tanaka H; Morimoto C
Eur J Immunol; 2002 May; 32(5):1328-37. PubMed ID: 11981820
[TBL] [Abstract][Full Text] [Related]
17. CD82, and CD63 in thyroid cancer.
Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
[TBL] [Abstract][Full Text] [Related]
18. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein.
Phillips KK; White AE; Hicks DJ; Welch DR; Barrett JC; Wei LL; Weissman BE
Mol Carcinog; 1998 Feb; 21(2):111-20. PubMed ID: 9496911
[TBL] [Abstract][Full Text] [Related]
19. A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Abe M; Sugiura T; Takahashi M; Ishii K; Shimoda M; Shirasuna K
Cancer Lett; 2008 Aug; 266(2):163-70. PubMed ID: 18395972
[TBL] [Abstract][Full Text] [Related]
20. CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells.
Mantegazza AR; Barrio MM; Moutel S; Bover L; Weck M; Brossart P; Teillaud JL; Mordoh J
Blood; 2004 Aug; 104(4):1183-90. PubMed ID: 15130945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]